The market knows what fair value is. No doubt they were involved in the raising, and desperately want to dump their shares. Nice try.
The truth is that PI-88 has now been confirmed as a much more narrowly focussed drug, and failed to meet any endpoints in a cancer trial of the most closely-related tissue type. The impact on potential revenue is devastating, and there is no way of sugar-coating it. PI-88 was priced as a drug for multiple conditions, and now it's been demonstrated as merely a specialty drug, with a small target market.
Good luck partnering a drug without broad efficacy. It just doesn't happen.
All hope now rests with their next-generation compound. Price target $1.50.
- Forums
- ASX - By Stock
- analysts do not have a clue
The market knows what fair value is. No doubt they were involved...
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PGL (ASX) to my watchlist
|
|||||
Last
44.0¢ |
Change
-0.005(1.12%) |
Mkt cap ! $72.48M |
Open | High | Low | Value | Volume |
44.5¢ | 44.5¢ | 44.0¢ | $226.1K | 509.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 959885 | 44.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
45.0¢ | 277803 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 959885 | 0.440 |
1 | 22800 | 0.435 |
3 | 8500 | 0.350 |
1 | 2500 | 0.200 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.450 | 277803 | 10 |
0.455 | 990 | 1 |
0.460 | 100000 | 1 |
0.490 | 21811 | 2 |
0.500 | 2000 | 1 |
Last trade - 14.08pm 23/07/2024 (20 minute delay) ? |
Featured News
PGL (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & MD
Charles Armstrong
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online